Baliopharm Overview

  • Founded

  • 2011

Founded
  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

  • Investments

  • 1

Baliopharm General Information

Description

Developer of biotechnological therapeutic drugs in Basel, Switzerland. The company's products include therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn's disease, psoriasis and multiple sclerosis, enabling physicians and doctors to enhance their treatment procedures.

Contact Information

Website
www.baliopharm.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Cellaïon
Primary Office
  • Stänzlergasse 4
  • 4051 Basel
  • Switzerland
+41 061 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baliopharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Baliopharm‘s full profile, request access.

Request a free trial

Baliopharm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biotechnological therapeutic drugs in Basel, Switzerland. The company's products include therapeutics for t
Biotechnology
Basel, Switzerland
000000&0

000000

r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ul
000000000000000
Mountain View, CA
000 As of 0000
00000
0.00 0000-00-00
000000&0 00000

00-000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000 000000000
Utrecht, Netherlands
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Baliopharm Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Chemocentryx Formerly VC-backed Mountain View, CA 000 00000 000000&0 00000
00-000000 Venture Capital-Backed Utrecht, Netherlands 00 00000 000000 - 000 00000
00000000 000000000 Formerly VC-backed Switzerland 00 00000 000000000 00000
000000 000000 Corporation London, United Kingdom 00 00000 000000000 00000
0000000 Accelerator/Incubator Backed Wilmington, DE 0 00.00 00000 00.00
You’re viewing 5 of 34 competitors. Get the full list »

Baliopharm Patents

  • 19

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Baliopharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11028178-B2 Method of treating nonalcoholic steatohepatitis by administering an antagonist human tumor necrosis factor receptor 1 (hutnfr1) antibody Active 27-Nov-2017 00000000
AU-2018371232-A1 Anti-hutnfr1 therapy of nonalcoholic steatohepatitis Pending 27-Nov-2017 00000000
CA-3081493-A1 Anti-hutnfr1 therapy of nonalcoholic steatohepatitis Pending 27-Nov-2017 00000000
EP-3717068-A1 Anti-hutnfr1 therapy of nonalcoholic steatohepatitis Pending 27-Nov-2017 00000000
US-20200299396-A1 Anti-hutnfr1 therapy of nonalcoholic steatohepatitis Active 27-Nov-2017 A61P1/16
To view Baliopharm’s complete patent history, request access »

Baliopharm Executive Team (1)

Name Title Board Seat Contact Info
Andreas Herrmann Ph.D Chief Executive Officer
To view Baliopharm’s complete executive team members history, request access »

Baliopharm Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 05-Jul-2016 0000 00000 00000 Drug Discovery
To view Baliopharm’s complete investments history, request access »